Trial
PHN-0296
2026-10-07 19:00 CT
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
ClinicalTrials.gov: peptide AND aging
A ClinicalTrials.gov listing marks as completed a study of how roflumilast and sitagliptin affect blood sugar, insulin, and gut hormones in healthy volunteers aged 21–55. Researchers investigated whether the drugs may increase GLP-1; the provided excerpt contains no results.
Clinical trialOriginal source ↗